ロード中...
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
OBJECTIVES: : Novel treatments for hepatitis C demonstrate high cure rates, but current high prices can be a barrier to rapid global treatment scale-up. Generic competition can rapidly lower drug prices. Using data on exports of raw materials in 2015, we calculated currently feasible generic prices...
保存先:
| 出版年: | J Virus Erad |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mediscript Ltd
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4946692/ https://ncbi.nlm.nih.gov/pubmed/27482432 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|